Related Experiment Video
Updated: May 16, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Drug-induced atrial fibrillation: does it matter?
Juan Tamargo1, Ricardo Caballero, Eva Delpón
1Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid 28040, Spain. jtamargo@med.ucm.es
Discovery Medicine
|December 4, 2012
Summary
Drug-induced atrial fibrillation (AF) is an underrecognized complication. Reviewing patient medication history is crucial for identifying potential drug triggers for new-onset AF.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Atrial fibrillation (AF) is a significant cause of morbidity and mortality.
- Numerous cardiovascular and non-cardiovascular drugs are implicated in inducing AF.
- Drug-induced AF (DIAF) is particularly concerning in the elderly and those with comorbidities.
Purpose of the Study:
- To highlight the underrecognized issue of drug-induced atrial fibrillation (DIAF).
- To emphasize the need for further research into DIAF's incidence, risk factors, and consequences.
- To recommend reviewing medication history in new-onset AF cases.
Main Methods:
- Review of clinical reports on drug-induced arrhythmias.
- Discussion of the potential increased risk in specific patient populations (elderly, comorbidities).
- Identification of knowledge gaps regarding DIAF epidemiology and outcomes.
Main Results:
- An increasing number of medications are identified as potential inducers of AF.
- DIAF often goes unrecognized due to its transient nature and lack of physician awareness.
- Epidemiological data on DIAF is currently lacking.
Conclusions:
- Drug-induced AF is a clinically relevant but understudied condition.
- Further research is essential to understand DIAF's incidence, risk factors, and impact on thromboembolism and mortality.
- Clinicians should consider medication review in patients presenting with new-onset AF.
Related Concept Videos
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
01:29Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...